| Literature DB >> 34094891 |
Erika Zago1, Nicolas Joly1, Ludovic Chaveriat1, Vincent Lequart1, Patrick Martin1.
Abstract
Glycolipids, carbohydrate fatty esters or sugar esters are amphiphilic molecules containing hydrophilic groups bonded to hydrophobic parent structures. Recently, glycolipids have shown their antimicrobial and antitumor capacities. Their surface activity properties have applications in the food, pharmaceutical and cosmetic industries. Sugar esters' building blocks can be obtained from natural resources and/or be transformed by biochemical pathways for uses as surfactants. Biosurfactants are non-ionic, nontoxic, biodegradable, tasteless, and odourless. The biocatalysis of these molecules involves sustainable, green, and safer methods. The advantages of producing biosurfactants from enzymatic catalysis are the energy economy, high selectivity, production of natural products, reduction of the use of fossil-based solvents and chloride compounds. This review presents the most recent studies concerning the evaluation of the impact of the main parameters and their levels influencing the enzymatic synthesis of glycolipids. Various enzyme catalysed synthetic methods were described. The parameters studied were temperature, reaction time, solvent system, type of biocatalyst, substrates molar ratio proportion and the nature of substrates. This review discusses the influence of different biocatalysts in the conversions of glycolipids; The reactivity from mono to polysaccharides and their interaction with fatty acids of different carbon chain lengths in the presence of specific enzymes; The effect of the solvent polarity, the use of multiple solvents, ionic liquids, supercritical CO2, and solvent-free media in sugar ester conversions; And the optimization of temperature and reaction time in different enzymatic systems.Entities:
Keywords: Biocatalysis; Biosurfactants; Enzymes; Glycolipids; Sugar esters
Year: 2021 PMID: 34094891 PMCID: PMC8166767 DOI: 10.1016/j.btre.2021.e00631
Source DB: PubMed Journal: Biotechnol Rep (Amst) ISSN: 2215-017X
Main parameters influencing the biocatalytic synthesis of amphiphilic carbohydrates in recent studies.
| Saccharide (carbohydrate) | Acyl donor | Enzyme | Solvents (v/v) | Time (h) | Saccharide/acyl donor (molar ratio) | T (°C) | Conversion of fatty acyl donor (%) | Refs |
|---|---|---|---|---|---|---|---|---|
| Glucose | Vinyl palmitate (C16) | Acetonitrile | 72 | 1:1 | 45 | 100 % | [ | |
| Glucose | N-lauroyl glycine (C12) | Novozym 435 ( | THF/n-hexane (1:1) | 9 | 1:1,5 | 55 | 52 % | [ |
| Glucose | Palmitic acid (C16:0) | Novozym 435 ( | Acetone saturated with CO2 | 4 | 1:2 | 50 | > 20 % | [ |
| Glucose | Vinyl laurate (C12:0) | Novozym 435 ( | IL* solutions | 12 | 1:2 | 40 | 55 % | [ |
| Glucose | Caproic acid (C6:0) | DMSO/tert-butanol (8:2) | 24 | 1:3 | 55 | 113 % | [ | |
| Glucose | Lauric acid (C12:0) | DMSO/tert-butanol (8:2) | 24 | 1:3 | 55 | 77 % | ||
| Glucose | Palmitic acid (C16:0) | DMSO/tert-butanol (8:2) | 24 | 1:3 | 55 | 97 % | ||
| Fructose | Lauric acid (C12:0) | IL*/2-methyl-2-butanol (6:4) | 12 | 1:1 | 50 | 85 % | [ | |
| Fructose | Oleic acid (C18:1) | Novozym 435 ( | Ethanol | 72 | 1:1 | 40 | 74 % | [ |
| Fructose | Oleic acid (C18:1) | Novozym 435 ( | Ethanol | 38 | 1,2:1 | 57 | 88 % | [ |
| Sucrose | Oleic acid (C18:1) | Novozym 435 ( | Ethanol | 72 | 1:1 | 40 | 56 % | |
| Lactose | Oleic acid (C18:1) | Novozym 435 ( | Ethanol | 72 | 1:1 | 40 | 84 % | |
| Xylose | Caproic acid (C6:0) | Novozym 435 ( | DMSO/Acetone (1:10) | 24 | 1:4 | 60 | 64 % | [ |
| D-Xylose | Vinyllaurate (C12:0) | Novozym 435 ( | 2-methylbutan-2-ol | 4 | 1:3 | 50 | 25 % | [ |
| Mannose | Lauric acid (C12:0) | Novozym 435 ( | n-hexane/acetone (1:1) | 72 | 1:4 | 50 | 25 % | [ |
| Mannose | Hemifluorinated acid derivatives | Novozym 435 ( | 2-methyl-2-butanol | 24 | 1:2 | 80 | 19 % | [ |
| Maltose | Linoleic acid (C18:2) | Novozym 435 ( | Acetone | 72 | 1:2 | 65 | 19 % | [ |
| Maltose | Lauric acid (C12:0) | Novozym 435 ( | Acetone/n-hexane (6:4) | 72 | 1:4 | 50 | 34 % | [ |
| Arabinose | Palmitic acid (C16:0) | Novozym 435 ( | DMSO/tert-butanol (1:9) | 24 | 1:1 | 60 | 22 % | [ |
| Trehalose | Lipoic acid (C8) | Novozym 435 ( | DMSO/2-methyl-2-butanol (4:1) | 96 | 1:4 | 40 | 19 % | [ |
| Oligo fructose | Caprilic acid (C8:0); Lauric acid (C12:0); Palmitic acid (C16:0); Stearic acid (C18:0) | Novozym 435 ( | DMSO/butanol (1:9) | 69 | 1:3 | 60 | C18 > C16 > C12 > C8 | [ |
| Starch | Palmitic acid (C16:0) | Novozym 435 ( | Solvent-free | 4 | 1:5 | 60 | 70 % | [ |
| Trehalose | Palmitic acid (C16:0) | Fermase CALBTM 10000 lipase | Acetone | 4 | 1:5 | 60 | 14 % | [ |
| Glucose | Fatty acids of coconut oil (C8:0; C10:0; C12:0; C14:0; C18:0; C18:1; C18:2; C18:3) | n-hexane | 16 | 1:60 | 40 | 9% | [ | |
| Fructose | Oleic acid (C18:1) | Solvent-free | 48 | 1:4 | 60 | 80 % | [ | |
| Lactose | Capric acid (C10:0) | Acetone | 48 | 1:1 | 55 | 67 % | [ | |
| Ribose | Capric acid (C10:0) | Acetone | 48 | 1:1 | 55 | 63 % | ||
| Mannose | Capric acid (C10:0) | Acetone | 48 | 1:1 | 55 | 62 % | ||
| Trehalose | Capric acid (C10:0) | Acetone | 48 | 1:1 | 55 | 56 % | ||
| D-galactose | Oleic acid (C18:1) | Lypozyme RM IM ( | DMSO/IL* (1:20) | 2 | 1:2 | 60 | 77 % | [ |
| α−β-galactose | N-decanoylglycine (C10) | Lypozyme TL IM ( | 6 | 1:1,5 | 40 | 94 % | [ | |
| Vinyllaurate (C12:0) | Lipozyme 435 (L435) (lipase B from | n-hexane | 96 | nc** | 60 | 80 % | [ | |
| Fructose | Oleic acid (C18:1) | Lipozyme IM | Solvent-free | 144 | 1:4 | 65 | 19 % | [ |
| Maltodextrin | Capric acid (C10:0); Lauric acid (C12:0); Palmitic acid (C16:0) | DMSO | 4 | 1:0,5 | 60 | C10 > C12 > C16 | [ | |
| Glucose | Divinyladipate | DMF | 120 | 1:4 | 50 | 80 % | [ | |
| Isomaltriose | Palmitic acid vinyl ester (C16:0) | DMSO | 24 | 1:1 | 45 | 90 % | [ |
*IL: Ionic liquids**.
nc: Not cited.